Skip to main content

Parliament dissolved ahead of election

The Scottish Parliament is now dissolved ahead of the election on Thursday 7 May 2026.

During dissolution, there are no MSPs and no parliamentary business can take place.

For more information, please visit Election 2026

Loading…

Search

There are 15,358 results relating to "Medicin Viagra-m"

Order by |

Refine your search

Select from the available filters to refine your search


Available filters:

Can't find what you're looking for?

If you're having trouble finding the information you want, please contact [email protected].

Questions and Answers Date answered: 20 September 2022

S6W-10447

The Scottish Medicines Consortium (SMC) is a partner in a UK-wide multi-agency RAPID C-19 initiative, which is a collaborative partnership between the SMC and the National Institute for Health and Care Excellence (NICE).
Questions and Answers Date answered: 9 August 2021

S6W-01217

This vaccine also complies with European Medicines Agency requirements and is shown on the record of vaccination as Vaxzevria - EU/1/21/1529.
Questions and Answers Date answered: 16 June 2021

S6W-00291

These trials are active in Scotland and the Scottish Government is closely monitoring the outcomes of these to ensure medicines with the greatest impact in treating COVID-19 are available for patients in Scotland.
Questions and Answers Date answered: 10 March 2021

S5W-35550

Year Funding delivered European Funding Streams (a) Scottish Enterprise**   (b) Other public bodies (incl SG) (c) Private Sector leverage  £m £m £m £m £m 2017 22.7 2.3 3.3 - 1...
Last updated: 21 November 2025

BB20251121

Members are advised to lodge amendments in good time before the beginning of a Stage and as early as possible during the day. (G) = Government Bill; (M) = Member’s Bill; (C) = Committee Bill; (P) = Private Bill; (H) = Hybrid Bill.
Questions and Answers Date answered: 18 November 2020

S5W-33094

Where sub-totals for type of measures funded and sector were specified, funding can be broken down by sector as follows: (a) Business Buildings - Via SME Loan Scheme Financial year Value of loans paid (£) 2015-16 £1,289,009 2016-17 £910,486 2017-18 £1,850,520 2018-19 £2,662,054 2019-20 £2,286,498 Total £8,998,567 (b) Loans to local authorities through Salix Finance :   Year Number Value (£) 2015-16 30 £2,445,394 2016-17 58 £5,372,606 2017-18 90 £5,646,158 2018-19 59 £6,790,785 2019-20 86 £8,965,149 Total 323 £29,220,091   (c) social housing through HEEPS Loans Scheme for RSLs Financial year Value of loans paid (£) 2016-17 £3,833,986 2017-18 £2,165,104 2018-19 £1,676,641 2019-20 £1,408,910 Total £7,816,622   (d) domestic housing Year 2015-16 16-17 17-18 18-19 19-20 Total  (£m...
Last updated: 12 February 2026

BB20260212

Members are advised to lodge amendments in good time before the beginning of a Stage and as early as possible during the day. (G) = Government Bill; (M) = Member’s Bill; (C) = Committee Bill; (P) = Private Bill; (H) = Hybrid Bill.
Last updated: 5 June 2023

The Carers Assistance Carer Support Payment Scotland Regulations 2023 3 March 2023

Serving members of His Majesty’s forces, civil servants and their family members 8.—(1) A relevant individual is to be treated as meeting the residence and presence conditions set out in regulations 6(1)(a), (b) and (d) where on any day that individual is outside the common travel area— (c) by reason of their capacity mentioned in paragraph (3)(a) provided that the individual satisfied the residence and presence conditions set out in regulation 6(1)(a), (b) and (d) immediately prior to the start of their employment mentioned in paragraph (3)(a), or (d) by reason of being a person mentioned in paragraph (3)(b) living with an individual to whom paragraph (3)(a) applies. (2) The past presence test set out in regulation 6(1)(e) does not apply to a relevant individual. (3) A “relevant individual” in paragraph (1) and (2) means an individual who is— (a) outside of the common travel area in their capacity as a— (i) serving member of His Majesty’s forces, or (ii) civil servant, or (b) living with a person mentioned in sub-paragraph (a) and— (i) is the child, step-child or child in care of that person, (ii) is the parent, step-parent or parent-in-law of that person, or (iii) is married to or in a civil partnership with that person, or is living together with that person as if they were married or in a civil partnership. (4) In this regulation— “child in care” means— 7 (a) under the law of Scotland, a child in respect of whom a relevant individual listed in paragraph (3)(a)— (i) is a foster carer within the meaning of regulation 2 of the Looked After Children (Scotland) Regulations 2009,(a) (ii) is a kinship carer within the meaning of regulation 2 of the Looked After Children (Scotland) Regulations 2009, (iii) has a kinship care order within the meaning of section 72 of the Children and Young People (Scotland) Act 2014,(b) or (b) under the law of England and Wales and Northern Ireland, a child in respect of whom a person listed in paragraph (3)(a) has a relationship equivalent to those listed under the law of Scotland, “civil servant” has the meaning given by section 1(4) of the Constitutional Reform and Governance Act 2010,(c) and "serving member of His Majesty's forces" means a member of a regular force or a reserve force ("M...
Questions and Answers Date answered: 5 January 2026

S6W-42786

To ask the Scottish Government what steps it is taking to ensure that adults with phenylketonuria (PKU) who are identified as responsive to sapropterin are able to access the medicine through the NHS. Healthcare Improvement Scotland (HIS) and the Inherited Metabolic Disorders (IMD) service in Scotland produced a statement on the use of sapropterin in indiv...
Questions and Answers Date answered: 13 November 2025

S6W-41675

The regulation for the licensing, safety and efficacy of medicines is currently reserved to the UK Government and is the responsibility of the Medicines and Healthcare products Regulatory Agency.

Can't find what you're looking for?

If you're having trouble finding the information you want, please contact [email protected].